Publications by authors named "Giuseppe AndO"

Claim this Profile
O
Oral anticoagulation with versus without antiplatelet therapy in patients with stable coronary artery disease and an indication for anticoagulation: a meta-analysis with trial sequential analysis.
Ahmed Ibrahim, Ali Saad Al-Shammari, Shrouk Ramadan, Yousif Hameed Kurmasha, Khadeeja Ali Hamzah

Expert Opin Pharmacother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[An unusual polyphasic deflection].
Pasquale Crea, Frank Coppolino, Giuseppe Andò

G Ital Cardiol (Rome)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of reduced-dose versus full-dose direct oral anticoagulants for extended treatment of venous thromboembolism: A meta-analysis with trial sequential analysis and reconstructed time-to-event data.
Ahmed Ibrahim, Laila Shalabi, Sofian Zreigh, Abdelrahman M Tawfik, Belal Mohamed Hamed

Thromb Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic therapy in complex percutaneous coronary intervention.
Domenico Simone Castiello, Angelo Oliva, Giuseppe Andò, Giampaolo Niccoli, Francesco Pelliccia

EuroIntervention· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-hospital platelet count dynamics in patients with acute coronary syndrome.
Andrea Zito, Antonio Landi, Andrea Milzi, Enrico Frigoli, Sergio Leonardi, Ferdinando Varbella

Rev Esp Cardiol (Engl Ed)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics, therapeutic strategies, and outcomes in elderly patients on oral anticoagulant therapy undergoing percutaneous coronary interventions: analysis of the PERSEO Registry.
Simona Minardi, Salvatore De Rosa, Nicolò Salvi, Giuseppe Andò, Giuseppe Talanas

J Geriatr Cardiol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cephalosporin triggered Kounis syndrome: Pathophysiological and clinical insights.
Cesare de Gregorio, Lucio Granata, Davide Raspanti, Federico Giannino, Claudia Cimino

Int J Cardiol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting System.
Maria Antonietta Barbieri, Giulia Russo, Giuseppe Cicala, Giuseppe Andò, Tindara Franchina

Eur J Clin Pharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leaving Nothing Behind: Expanding the Clinical Frontiers of Drug-Coated Balloon Angioplasty in Coronary Artery Disease.
Marcello Marchetta, Stefano Sasso, Vincenzo Paragliola, Valerio Maffi, Gaetano Chiricolo

J Cardiovasc Dev Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Insights in coronary artery disease: 2023.
Giuseppe Ando', Felice Gragnano, Marco Giuseppe Del Buono, Viktor Kočka, Marco Zimarino

Front Cardiovasc Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring Imaging Depth: A Pilot Study About 2D vs. 4D Echocardiography for Tricuspid Valve Evaluation.
Giuseppe Santarpino, Giovanni Taverna, Vincenzo Calabrese, Flavia Coviello, Giancarlo Trimarchi

Rev Cardiovasc Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Ticagrelor Monotherapy After Short-Duration Dual Antiplatelet Therapy in PCI Patients: A Systematic Review and Meta-Analysis.
Giulia Alagna, Giancarlo Trimarchi, Alessia Cascone, Alessio Villari, Giulia Cavolina

Am J Cardiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STARTing a new path in cardiovascular prevention: Lessons from SELECT and real-world evidence on Semaglutide in obesity-driven risk.
Giuseppe Andò, Giulia Cavolina, Alessio Villari, Pierre Sabouret, Giuseppe Musumeci

Int J Cardiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Inflammatory Diseases and Cardiovascular Risk: Current Insights and Future Strategies for Optimal Management.
Stefano Cacciatore, Silvia Andaloro, Marco Bernardi, Armando Oterino Manzanas, Luigi Spadafora

Int J Mol Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Efficacy and Safety of Inclisiran: A Single-Country, Multicenter, Observational Study (CHOLINET Registry).
Paola Gargiulo, Federica Marzano, Mario Crisci, Rossella Marcucci, Dario Bruzzese, Ferdinando Varbella

J Am Coll Cardiol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alleviating Refractory Angina Through Coronary Sinus Narrowing: Consistent Benefits and the Pursuit of Mechanistic Insights.
Giuseppe Andò, Rocco Antonio Montone

JACC Cardiovasc Interv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REPLY: Exercise-Based Cardiac Rehabilitation and Coronary Sinus Reducer in the Management of Stable Angina.
Rocco A Montone, Riccardo Rinaldi, Giuseppe Andò, Pasquale Perrone Filardi, Filippo Crea

J Am Coll Cardiol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The ETNA-AF Europe registry: 4-year data of edoxaban use in atrial fibrillation in the Italian real world compared to the European cohort].
Letizia Riva, Giuseppe Andò, Maurizio Anselmi, Roberto Cemin, Daniele Nassiacos

G Ital Cardiol (Rome)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Patients Treated With Oral Anticoagulant Therapy Undergoing Percutaneous Coronary Intervention With Stent Implantation: The PERSEO Registry.
Alessandro Sciahbasi, Salvatore De Rosa, Giuseppe Gargiulo, Daniele Giacoppo, Paolo Calabrò

J Cardiovasc Pharmacol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Acute Coronary Syndromes: Bridging Gaps in Diagnosis and Treatment.
Giuseppe Andò, Antonio Micari, Francesco Costa

J Clin Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optical Coherence Tomography in Myocardial Infarction Management: Enhancing Precision in Percutaneous Coronary Intervention.
Angela Buonpane, Giancarlo Trimarchi, Marco Ciardetti, Michele Alessandro Coceani, Giulia Alagna

J Clin Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Management of Stable Angina: A Patient-Centered Approach Integrating Revascularization, Medical Therapy, and Lifestyle Interventions.
Rocco A Montone, Riccardo Rinaldi, Giampaolo Niccoli, Giuseppe Andò, Felice Gragnano

J Am Coll Cardiol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-Status Outcomes in Older Patients With Myocardial Infarction: Physiology-Guided Complete Revascularization Versus Culprit-Only Strategy.
Gianluca Campo, Vincenzo Guiducci, Javier Escaned, Raul Moreno, Gianni Casella, Gerlando Pilato

Circ Cardiovasc Qual Outcomes· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Complex Hemodynamic Interplay between Mitral Arcade, Midventricular Obstruction, and Prosthetic Aortic Valve.
Giovanni Taverna, Antonino Micari, Olimpia Trio, Tommaso D'Angelo, Gianluca Di Bella

CASE (Phila)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathophysiology and Treatment of the No-Reflow Phenomenon in ST-Segment Elevation Myocardial Infarction: Focus on Low-Dose Fibrinolysis during Primary Percutaneous Intervention.
Francesco Pelliccia, Giampaolo Niccoli, Marco Zimarino, Giuseppe Andò, Italo Porto

Rev Cardiovasc Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis